October 11th 2024
The now-11-year odyssey to track drugs by item through the supply chain will be under a regulatory exemption for up to two years.
October 8th 2024
With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.
September 26th 2024
A panel offers its perspective on bolstering the temperature monitoring and data sharing process.
September 24th 2024
With the Nov. 27 deadline fast approaching, is the pharma supply chain ready for full data exchange?
September 19th 2024
The collaboration is centered around meeting track-and-trace requirements.
Pharma seeks growth in eyecare
New industry entrants aim at expanding patient volumes even while drug compounding limits some therapy classes
Advancing the biopharma cold chain
Vendors and service providers scramble to serve a growing market
When it Comes to Compliance, Learning Never Stops
2016 Product Security Report
Pharma spends heavily to secure its supply chain, while politicians bring out the re-importation topic
The 2015 Biopharma Cold Chain Landscape
More volumes of more valuable products drive growth
2015 PDMA Sharing Conference
A silver anniversary with golden opportunities
2015 Product Security Report
Meeting the compliance deadlines of the Drug Supply Chain Security Act has the attention of many in biopharma product and brand security
Commercial Data Sources for the Biopharma Industry
Finding the 'HUB' in Specialty Pharma Services
For specialty pharmaceuticals, the connection between manufacturer, payer and patient is the rising crop of hub services
Enabling item level serialization: Ten key steps to ensure success
What manufacturers should anticipate when working with specialty pharmacies
When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully
Specialty Pharmaceuticals: Facts and Figures
HDMA's fourth edition polling its members and manufacturers, on trends in specialty distribution
Improving efficiency, effectiveness of drug recalls
2012 Product Security Report
Serialization systems are going into operation around the world, but cross-industry collaboration awaits new legislation
Home infusion enhances specialty pharmaceutical distribution
With partial support from manufacturers themselves, home health services are emerging as a critical channel for specialties
Navigating the tense, complex oncology market
Oncology combines some of the most life-changing therapeutic events with the most complex commercialization pathways. Rising costs of treatments simply add to the tension
Adding rigor to the adverse event reporting process
As FDA makes progress on an active surveillance system, drug manufacturers and third-party drug safety vendors navigate their own set of challenges
Generics Manufacturers Grapple With Tight Economics
But the global picture is sunny as most of the global market growth benefits the generic makers
THE ONGOING DIABETES BATTLEGROUND
Even as diagnosed (and “prediabetes”) cases rise worldwide, healthcare providers struggle with patients to control the course of the disease. New therapies—and new health services—are aiding in the battle
For a Lucky Few, Biopharma Expansion a Reality Again
Trends in site selection, regional economic development and business expansion
The Struggle to Get Anti-Infectives on a Faster Track to Commercialization
A looming crisis in drug-resistant anti-infectives is not being met with a commensurate industry effort. Governments and industry are trying to cope
Rare Diseases and Orphan Drugs Lift Pharma Innovation
As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy
PDMA 2010: The Power of Sharing
The 2010 PDMA Sharing Conference: Expanding Our Focus With More Learning Opportunities
The Drive to Develop New Commercial Models
Industry’s coming challenges will force dramatic change on how products are brought to market and businesses are sustained. Industry leaders have already started the process
Site Selection 2010: Development Authorities Recalibrate Their Pitch as Biopharma Growth Slowly Rebounds
Faced with fierce competition, dwindling budgets and intense pressure to create jobs, economic development authorities are reinventing their recruitment strategies to attract life sciences employers
Optimization of 2-8 Degrees Celsius Controlled-Temperature Small Parcels
Patient Outcomes Research Moves Drug Development Beyond Clinical Results
Pharma Gets a 'Just in Time' Speedup With the Switch to Digital Printing
‘Print on demand’ changes traditional design, production and inventory practices for labels, inserts and other printed packaging
Putting Nursing Into the Pharmaceutical Usage Equation
While nurses move into a more central role in prescribing and administering pharmaceuticals, the nursing professions debate industry influence
The State of the Industry in Product Security
As legislative mandates have receded, manufacturers must undertake their own initiatives for protecting against counterfeits and diversion